Distinct patterns of antiamyloid-β antibodies in typical and atypical Alzheimer disease

Archives of Neurology

Volumn 69, Issue 9, 2012, Pages 1181-1185

  Dorothée, Guillaume ^a,b   Bottlaender, Michel ^c,d   Moukari, Edmond ^a,b   De Souza, Leonardo C ^b,e   Maroy, Renaud ^c   Corlier, Fabian ^b,e   Colliot, Olivier ^b,e   Chupin, Marie ^b,e   Lamari, Foudil ^e   Lehéricy, Stephane ^b,e   Dubois, Bruno ^b,e   Sarazin, Marie ^b,e   Aucouturier, Pierre ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^d SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CARBON 11; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M; OLIGOMER; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATYPICAL ALZHEIMER DISEASE; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; CROSS REACTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; TYPICAL ALZHEIMER DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIBODIES; BIOLOGICAL MARKERS; BRAIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PHOSPHORYLATION; TAU PROTEINS;

EID: 84866089622     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.604     Document Type: Article

References (14)

1. Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology. 2001;57(5):801-805. (Pubitemid 32845498)
2. Kellner A, Matschke J, Bernreuther C, Moch H, Ferrer I, Glatzel M. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol. 2009;65(1):24-31.
3. Britschgi M, Olin CE, Johns HT, et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A. 2009;106(29):12145- 12150.
4. Storace D, Cammarata S, Borghi R, et al. Elevation of β-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. Arch Neurol. 2010;67(7):867-872.
5. de Souza LC, Corlier F, Habert MO, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease. Brain. 2011;134(pt 7):2036-2043.
6. Rosenbloom MH, Alkalay A, Agarwal N, et al. Distinct clinical andmetabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011;76(21):1789-1796.
7. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9(11):1118-1127.
8. Koric L, Felician O, Ceccaldi M. Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice [in French]. Rev Neurol (Paris). 2011;167(6-7):474-484.
9. Aucouturier P, Mounir S, Preud'homme JL. Distribution of IgG subclass levels in normal adult sera as determined by a competitive enzyme immunoassay using monoclonal antibodies. Diagn Immunol. 1985;3(4):191-196. (Pubitemid 16185041)
10. Nath A, Hall E, Tuzova M, et al. Autoantibodies to amyloid beta-peptide (Aβ) are increased in Alzheimer's disease patients and Aβ antibodies can enhance Aβ neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med. 2003;3(1):29-39. (Pubitemid 37070580)
11. Hyman BT, Smith C, Buldyrev I, et al. Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol. 2001;49(6):808-810.
12. Rezai-Zadeh K, Gate D, Gowing G, Town T. How to get from here to there: macrophage recruitment in Alzheimer's disease. Curr Alzheimer Res. 2011;8(2):156-163.
13. Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol. 2011; 48(14):1592-1603.
14. Kas A, de Souza LC, Samri D, et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain. 2011;134(pt 5):1464-1478.